Skip to main content
logo
Cytokinetics logo
Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
62.79
-0.12 (-0.19%)
At close: Oct 12, 2026, 4:00 PM EDT
61.54
-1.25 (-1.99%)
After-hours: Oct 12, 2026, 7:30 PM EDT

Cytokinetics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
8,7297,7695,5518,1864,3363,823
Market Cap Growth
19.95%39.94%-32.19%88.80%13.41%159.96%
Enterprise Value
8,9888,1565,4488,3964,2103,612
Last Close Price
62.7963.5447.0483.4945.8245.58

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
129.0088.24300.501087.1845.8454.29
PB Ratio
--11.78-41.01-21.19-40.1815.68
P/TBV Ratio
-----15.68

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
132.8292.65294.901115.0344.5051.29

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-8.21-2.18-6.82-1.96-6.951.11
Net Debt / Equity Ratio
-1.49-0.841.13-0.360.30-0.83
Net Debt / EBITDA Ratio
-0.37-0.920.29-0.290.101.10
Net Debt / FCF Ratio
-0.45-1.040.38-0.340.101.05
Asset Turnover
0.040.060.020.010.100.10
Quick Ratio
6.564.456.086.009.257.35
Current Ratio
6.664.536.176.129.407.45
Return on Equity (ROE)
-----572.15%-120.54%
Return on Assets (ROA)
-28.09%-27.08%-30.11%-33.73%-21.83%-16.94%
Return on Capital Employed (ROCE)
-40.60%-50.10%-43.90%-68.80%-34.90%-24.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-10.24%-10.10%-10.62%-6.43%-8.97%-5.63%
FCF Yield
-6.65%-6.88%-7.20%-5.08%-7.17%-5.01%
Buyback Yield / Dilution
-5.07%-7.26%-16.01%-7.46%-16.83%-19.16%
SEC Filings: 10-K · 10-Q